Samah Hayek

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Coronavirus Disease

Top Venues

Infectious diseases and therapy

Diabetes, obesity & metabolism

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan, Ran D Balicer, Doron Netzer, Alon Peretz
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups. Infectious diseases and therapy 13 (6) (2024)
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan, Ran D Balicer, Doron Netzer, Alon Peretz
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups. Infectious diseases and therapy 13 (6) (2024)
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan, Ran D Balicer, Doron Netzer, Alon Peretz
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups. Infectious diseases and therapy 13 (6) (2024)
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan, Ran D Balicer, Doron Netzer, Alon Peretz
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups. Infectious diseases and therapy (2024)
Samah Hayek, Gilad Libresco, Noam Barda, Chun R Chao, Lanfang Xu, Kimberly L Cannavale, Shai Izraeli, Saro H Armenian
Chronic health conditions among long-term survivors of adolescent and young adult (AYA) cancer: A comparison of outcomes in Israel and the United States. Cancer (2023)
Samah Hayek, Yatir Ben-Shlomo, Noa Dagan, Ben Y Reis, Noam Barda, Eldad Kepten, Alina Roitman, Shachar Shapira, Shlomit Yaron, Ran D Balicer, Doron Netzer, Alon Peretz
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes. Nature communications 13 (1) (2022)
Samah Hayek, Galit Shaham, Yatir Ben-Shlomo, Eldad Kepten, Noa Dagan, Daniel Nevo, Marc Lipsitch, Ben Y Reis, Ran D Balicer, Noam Barda
Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science (New York, N.Y.) 375 (6585) (2022)
Samah Hayek, Yatir Ben-Shlomo, Ran Balicer, Katherine Byrne, Mark Katz, Eldad Kepten, Itamar Raz, Eytan Roitman, Marcin Zychma, Noam Barda
Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study. Diabetes, obesity & metabolism 23 (8) (2021)